{"Title": ["BUZZ-U.S. STOCKS ON THE MOVE-Oil stocks, airlines, Peloton, PayPal", "BUZZ-U.S. STOCKS ON THE MOVE-PayPal, GM, Lyft, airlines", "Esperion Therapeutics Breaks Above 200-Day Moving Average - Bullish for ESPR", "Esperion Therapeutics Inc (ESPR) Q1 2020 Earnings Call Transcript", "CYCC In STOPCOVID, EXEL Hits New High, NVS Trialing Malaria Drug For COVID-19", "Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?", "BUZZ-U.S. STOCKS ON THE MOVE-Gilead Sciences, Wayfair, Immunomedics, Akers Bioscience", "BUZZ-U.S. STOCKS ON THE MOVE-Carnival Corp, Capri Holdings, Kohl's, Immunomedics", "BUZZ-U.S. STOCKS ON THE MOVE-Oil stocks, airlines, Peloton, PayPal", "FDA Approves New LDL-C Lowering Drug, NEXLETOL", "FDA Approves Esperion Therapeutics' New Cholesterol Drug", "Noteworthy Friday Option Activity: ESPR, YUMC, VSAT", "4 Dates Biotech Investors Should Circle in February", "European Advisory Group Backs Esperion's Cholesterol Drugs", "Biotech Stocks Facing FDA Decision In February 2020", "Biotech's Most Volatile Binary Events for Q1", "Esperion Therapeutics Breaks Below 200-Day Moving Average - Notable for ESPR", "4 Healthcare Stocks With FDA Approvals on the Horizon", "Can Cannabis 2.0 Kickstart Marijuana Stocks?", "Notable Monday Option Activity: ESPR, DY, SPOT", "Esperion Therapeutics Breaks Above 200-Day Moving Average - Bullish for ESPR", "Analysts Forecast 10% Gains Ahead For The Holdings of VB", "7 Micro-Cap and Small-Cap Stocks That Insiders Are Buying", "Monday 9/9 Insider Buying Report: ACHC, ESPR", "Esperion (ESPR) Almost Doubled In 2019, What Awaits The Stock In 2020?", "Esperion Therapeutics Breaks Below 200-Day Moving Average - Notable for ESPR", "Notable Wednesday Option Activity: KEM, ESPR, BAC", "Health Care Sector Update for 05/06/2019: PODD,BHC,BHC.TO,ESPR,HMSY", "Health Care Sector Update for 05/06/2019: BHC,ESPR,HMSY", "Esperion Therapeutics (ESPR) Shares Cross Above 200 DMA", "Health Care Sector Update for 05/06/2019: ESPR, AXSM, CANF, JNJ, PFE, ABT, MRK, AMGN", "Commit To Buy Esperion Therapeutics At $25, Earn 17.2% Using Options", "Notable Monday Option Activity: ITW, ESPR, TEAM", "Notable Monday Option Activity: HRI, ESPR, CLVS", "Tuesday's ETF Movers: XBI, XOP", "Tuesday's ETF Movers: XBI, XOP", "Esperion (ESPR) Reports Wider-Than-Expected Loss in Q4", "Notable Two Hundred Day Moving Average Cross - ESPR", "For Esperion Therapeutics, 2019 Could Be a Big Year", "Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN", "Notable Monday Option Activity: HRI, ESPR, CLVS", "Notable Monday Option Activity: HRI, ESPR, CLVS", "Notable Thursday Option Activity: ESPR, ADBE, RGLD", "Look Under The Hood: FTXH Has 35% Upside", "Do Options Traders Know Something About Esperion (ESPR) Stock We Don't?", "What's Next for Esperion Therapeutics' Cholesterol-Lowering Drug", "ESPR Makes Bullish Cross Above Critical Moving Average", "3 Top Healthcare Stocks to Buy in October", "Why Arcus Biosciences, Eldorado Gold, and Esperion Therapeutics Slumped Today", "Notable Monday Option Activity: CMG, OSIS, ESPR", "Noteworthy Friday Option Activity: XLNX, PDCE, ESPR", "Notable Wednesday Option Activity: TWTR, FSLR, ESPR", "3 Biotech Stocks That Could Soar in September", "Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol", "Noteworthy Monday Option Activity: ESPR, BMY, WATT", "Commit To Purchase Esperion Therapeutics At $35, Earn 34.5% Annualized Using Options", "Tuesday's ETF Movers: XBI, KRE", "Health Care Sector Update for 08/17/2018: ESPR,VCEL,ARAY", "3 Top Biotech Stocks to Buy Right Now", "Options Traders Expect Huge Moves in Esperion Therapeutics (ESPR) Stock", "Oversold Conditions For Esperion Therapeutics (ESPR)", "Is Esperion Therapeutics Inc. a Buy on the Dip?", "Here's Why Esperion Therapeutics Inc. Stock Is Bouncing Back Today", "This Clinical-Stage Biotech's Tackling a Huge Health Issue, but It Has to Overcome Pessimistic Investors First", "Health Care Sector Update for 08/17/2018: CGC,ARAY,ESPR,VCEL", "Esperion Therapeutics Inc Shares Plunge on Cholesterol Drug Safety Concerns", "Mid-Morning Market Update: Markets Mixed; Apple Earnings Top Expectations", "Here's Why Esperion Therapeutics Dropped as Much as 36.9% Today", "3 Top Healthcare Stocks to Buy Right Now", "Is the Options Market Predicting a Spike in Esperion (ESPR) Stock?", "10 Small-Cap Growth Stocks to Buy Now", "Results Renew Optimism for Esperion Therapeutics", "Why Esperion Therapeutics Shares Are Crashing (Again!) Today", "Regeneron Takes Aim at Amgen and Esperion Therapeutics", "Why Esperion Therapeutics' Shares Fell Despite Its Good News", "Health Care Sector Update for 03/07/2018: ESPR, APTO, FLKS, TRVN", "Is the Options Market Predicting a Spike in Esperion (ESPR) Stock?", "3 Top Cholesterol Drug Stocks to Consider Buying Now", "Notable Friday Option Activity: BLK, ESPR, CZR", "Why Esperion Therapeutics Shares Skyrocketed 425.9% in 2017", "Notable Tuesday Option Activity: GPRO, ESPR, INTC", "Beware: Price Wars For Big Pharma, Biotech Companies On Horizon", "Noteworthy Wednesday Option Activity: DISH, ESPR, GOOG", "3 Stocks That Quadrupled", "Esperion Therapeutics Becomes Oversold (ESPR)", "Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down", "These Stocks Have Quadrupled Since Last Year", "The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant", "Commit To Purchase Esperion Therapeutics At $28, Earn 20.4% Using Options", "Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure", "Here's What's Pushing Up Esperion Therapeutics Inc. Today", "Health Care Sector Update for 08/08/2017: ESPR", "Perrigo Company (PRGO) Q2 Earnings: What's in the Cards?", "Should You Buy Esperion Therapeutics (ESPR) Ahead of Earnings?", "What's in Store for Intrexon (XON) in this Earnings Season?", "What's in the Cards for Endo (ENDP) this Earnings Season?", "Boxer Capital, LLC Buys Macrogenics Inc, G1 Therapeutics Inc, iPath S&P 500 VIX Short Term ...", "Is a Beat in Store for Ionis (IONS) This Earnings Season?", "Juno Therapeutics (JUNO) Q2 Earnings: Surprise in Store?", "The CEO Behind Lipitor Is Working on a Promising New Cholesterol Drug", "3 Been-There-Done-That Biotech CEOs Who Are Doing it Again", "Thursday's ETF Movers: XBI, OIH", "3 Small Biotech Stocks Being Run by Proven Winners", "The Zacks Analyst Blog Highlights: Merck, Sanofi, Roche, Esperion and Teva", "What to Expect from Epizyme (EPZM) This Earnings Season?", "Esperion Therapeutics (ESPR) Looks Good: Stock Gains 10.4%", "Esperion's Combo Cholesterol Candidate Enters Phase III", "Here's Why Shares of Esperion Therapeutics (ESPR) Popped Today", "Notable Wednesday Option Activity: ESPR, AAPL, CMG", "If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy", "Wednesday's ETF with Unusual Volume: IBB", "Wednesday's ETF Movers: XBI, XOP", "3 Stocks That Turned $7,000 Into As Much As $37,000 So Far in 2017", "Why Esperion Therapeutics Shares Were Flat In April", "3 Best Biotech Stocks During Trump's First 100 Days", "3 Clinical-Stage Biotech Stocks That Could Be About to Strike It Rich", "The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics", "Could Pfizer Buy Esperion Therapeutics?", "3 Hot Biotech Stocks Now", "Company News for March 21, 2017", "Commit To Purchase Esperion Therapeutics At $27, Earn 21.2% Annualized Using Options", "Pre-Market Most Active for Mar 20, 2017 : LYG, ARRY, ESPR, GNMX, HMC, NKTR, DB, SNY, SYT, BAC, ARLZ, ASML", "Here's What Pushed Esperion Therapeutics Inc Stock Higher Today", "Close Update: Wall Street Struggles to Find Direction With Fed Speakers in Focus", "Health Care Sector Update for 03/20/2017: CTMX,BMY,ESPR,CERU,NVS", "Health Care Sector Update for 03/20/2017: NKTR,ESPR,CERU", "Notable Friday Option Activity: HPT, ESPR, LMT", "Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today", "Pre-Market Most Active for Mar 21, 2017 : DB, NOK, AUPH, FCX, AAPL, FCAU, ESPR, QQQ, BAC, SPIL, FB, MT", "4 Biotech Stocks Breaking Out On Positive Drug Developments", "Here's Why Esperion Therapeutics Inc Stock Popped Today", "3 Biotech Long Shots: Boom Or Bust?", "4 Stocks to Watch, Led by Biotech", "Why Esperion Therapeutics, Inc. Is Soaring Today", "Noteworthy Friday Option Activity: TSRO, ESPR, LOPE", "Notable Friday Option Activity: ESPR, SMG, W", "Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%", "Noteworthy Tuesday Option Activity: ESPR, OPHT, FDS", "Is Esperion Therapeutics (ESPR) Stock a Solid Choice Right Now?", "Esperion Director buys 4,400 shares", "Thursday 7/7 Insider Buying Report: ESPR, XPLR", "Esperion (ESPR) Offers Updates on LDL-Lowering Candidate", "Why AeroVironment, Southwestern Energy, and Esperion Therapeutics Slumped Today", "Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters", "Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%", "Noteworthy Tuesday Option Activity: ESPR, OPHT, FDS", "Is Esperion Therapeutics (ESPR) Stock a Solid Choice Right Now?", "Tuesday's ETF Movers: GDX, XBI", "Health Care Sector Update for 02/26/2016: ESPR, KERX", "Wednesday 1/20 Insider Buying Report: FMO, ESPR", "Why Chimerix Inc. Is Up Big Today", "Why Alcoa Inc (AA), Esperion Therapeutics Inc (ESPR) and Southwestern Energy Company (SWN) Are 3 of Today\u2019s Worst Stocks", "Esperion Therapeutics Inc Sinks After FDA Says, \"Ask Us in 2019\"", "Russell 2000 Headed 14% Higher, If Analysts Got The Components Right", "Component Price Targets Imply 17% Gains Ahead For Russell 2000", "Endocyte (ECYT) Posts Narrower-than-Expected Loss in Q3", "Eli Lilly's Failure Is a Success for These Companies", "Pre-Market Most Active for Oct 12, 2015 : EMC, LLY, PSTG, AAPL, SNY, ALU, ABX, ESPR, TVIX, XIV, MU, NFLX", "Winners and Losers of Eli Lilly's CETP Drug Failure", "Esperion (ESPR) Initiates Phase III Study for Hyperlipidemia", "Esperion Plunges on FDA Advice for Cardiovascular Study", "Health Care Sector Update for 09/30/2015: ESPR,MDWD,HAE", "Why Esperion Therapeutics, Inc. Stock Cratered Today", "Health Care Sector Update for 09/29/2015: EGRX, ESPR, GTXI", "Tuesday's ETF Movers: GDX, XBI", "Tuesday Sector Laggards: Waste Management, Drugs", "Esperion Updates on its Cholesterol Management Candidate", "Health Care Sector Update for 09/30/2015: ESPR, BLPH, OGXI", "Esperion Therapeutics (ESPR) Catches Eye: Stock Up 14.1%", "Esperion (ESPR) Sees Hammer Chart Pattern: Time to Buy?", "After Hours Most Active for Aug 17, 2015 : ABBV, ABEV, SUNE, CCP$, TSM, HST, URBN, ESPR, CENX, QQQ, CAR, MSFT", "Monday's ETF Movers: XBI, PIN", "Esperion Therapeutics (ESPR) Looks Good: Stock Up 16.3% - Tale of the Tape", "Health Care Sector Update for 08/10/2015: PMC, MYL, ESPR", "Esperion Therapeutics Becomes Oversold (ESPR)", "Is Esperion's Good News Actually Bad?", "Esperion Therapeutics (ESPR) Jumps: Stock Rises 7.1% - Tale of the Tape", "Health Care Sector Update for 07/07/2015: ESPR,DEPO,HZNP,ETRM", "Pabrai Funds 2014 Investor Meeting Notes", "Health Care Sector Update for 06/25/2015: OPRN, ESPR, MACK", "Health Care Sector Update for 06/24/2015: ALDR, PTLA, ESPR", "Calls target Esperion Therapeutics", "Cholesterol Drug Blues: Why Esperion Therapeutics' Stock Is Getting Crushed Today", "The FDA Breathes New Life Into Esperion's ETC-1002", "Esperion Therapeutics (ESPR) Jumps: Stock Rises 7.1% - Tale of the Tape", "Health Care Sector Update for 04/23/2015: STJ, ESPR, ADPT", "3 Biotech Stocks That Could Be Developing Billion Dollar Drugs", "3 Top Healthcare Stocks Surging Higher This Year", "The 3 Best Stocks for Investing in Cholesterol Drugs", "Here's How Esperion Therapeutics, Inc. Could Get to $140", "Healthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout Targets", "Pre-Market Most Active for Jun 10, 2015 : NEM, GSK, ASX, NOK, HCC, CAJ, ISSI, GPRO, AAPL, ESPR, XIV, QQQ", "3 Biotech Stocks That Dropped Yesterday -- Is 1 a Buy?", "Weakness Seen in Esperion Therapeutics (ESPR): Stock Tumbles 8.8% - Tale of the Tape", "Why Esperion Therapeutics, Inc. Shares Burst Today.", "1 Tiny Biotech's Blockbuster Opportunity in Heart Disease", "Health Care Sector Update for 03/19/2015: FLML, NBIX, ESPR, CAPR", "Why Esperion Therapeutics, Inc. is Sky-Rocketing Higher", "Esperion Therapeutics (ESPR) Jumps: Stock Rises 29.2% - Tale of the Tape", "3 Little-Known Biotechs Working On Potential Blockbusters", "Why Esperion Therapeutics Inc. Stock Bolted Higher Today", "Health Care Sector Update for 03/17/2015: ESPR,CNAT", "After-Hours Earnings Report for March 5, 2015 : COO, ESL, WX, FNSR, TFM, YY, MMI, ESPR, TTPH, EBS, JOBS, ENT", "3 All-or-Nothing Biotech Stocks We're Closely Watching", "Esperion Therapeutics (ESPR) Jumps: Stock Rises 15.6% - Tale of the Tape", "Why Esperion Therapeutics Inc. Shares Skyrocketed Today", "Esperion Therapeutics (ESPR) Shares March Higher, Can It Continue? - Tale of the Tape", "Esperion Soars on Positive Phase IIb Data on ETC-1002 - Analyst Blog", "Can The Uptrend Continue for Esperion (ESPR)? - Tale of the Tape", "Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too", "Esperion Therapeutics Slumps: ESPR Falls 6.3% in Session - Tale of the Tape", "Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?", "Esperion Therapeutics (ESPR) in Focus: Stock Jumps 5.1% - Tale of the Tape", "Sector Update: Health Care Stocks Again Springing Leaks; Esperion Therapeutics Climbs to Record High on Positive Test Results for Anti-Cholesterol Drug", "Sector Update: Health Care", "Can the Rally in Esperion Therapeutics (ESPR) Shares Continue? - Tale of the Tape", "Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% - Tale of the Tape", "NASDAQ Biotechnology Top Performers (As Of Market Open September 11)", "MediWound (MDWD) Falls: Stock Goes Down 6.1% - Tale of the Tape", "Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape", "Esperion Therapeutics (ESPR) in Focus: Stock Moves 5.6% Higher - Tale of the Tape", "US IPO Recap: Market picks up the pace with ten IPOs, six price below the range", "Esperion Therapeutics prices upsized IPO at $14, the midpoint of the range", "Esperion (ESPR) is in Overbought Territory: What's Next? - Tale of the Tape", "Esperion Therapeutics files for a $70 million IPO", "Biotech Esperion Therapeutics sets terms for $63 million IPO"], "Elapsed Time": ["MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "APR 21, 2020", "APR 15, 2020", "APR 6, 2020", "APR 6, 2020", "MAY 7, 2020", "FEB 22, 2020", "FEB 21, 2020", "FEB 7, 2020", "FEB 6, 2020", "JAN 31, 2020", "JAN 28, 2020", "JAN 3, 2020", "MAR 9, 2020", "DEC 12, 2019", "DEC 6, 2019", "NOV 18, 2019", "NOV 18, 2019", "NOV 12, 2019", "SEP 9, 2019", "SEP 9, 2019", "JAN 3, 2020", "JUN 28, 2019", "MAY 15, 2019", "MAY 6, 2019", "MAY 6, 2019", "MAY 6, 2019", "MAY 6, 2019", "APR 24, 2019", "AUG 5, 2019", "APR 15, 2019", "APR 2, 2019", "APR 2, 2019", "MAR 1, 2019", "FEB 6, 2019", "JAN 11, 2019", "JAN 4, 2019", "APR 15, 2019", "JAN 4, 2019", "DEC 20, 2018", "DEC 17, 2018", "NOV 14, 2018", "NOV 8, 2018", "NOV 2, 2018", "OCT 20, 2018", "JAN 4, 2019", "OCT 8, 2018", "SEP 28, 2018", "SEP 12, 2018", "SEP 2, 2018", "AUG 28, 2018", "AUG 27, 2018", "AUG 22, 2018", "OCT 16, 2018", "AUG 17, 2018", "AUG 13, 2018", "JUL 10, 2018", "MAY 24, 2018", "MAY 8, 2018", "MAY 4, 2018", "MAY 4, 2018", "AUG 17, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 2, 2018", "MAY 1, 2018", "APR 30, 2018", "APR 26, 2018", "MAR 27, 2018", "MAY 3, 2018", "MAR 12, 2018", "MAR 7, 2018", "MAR 7, 2018", "MAR 2, 2018", "FEB 6, 2018", "JAN 12, 2018", "JAN 6, 2018", "MAR 27, 2018", "DEC 15, 2017", "DEC 6, 2017", "DEC 4, 2017", "OCT 23, 2017", "OCT 11, 2017", "AUG 18, 2017", "AUG 14, 2017", "DEC 21, 2017", "AUG 11, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 2, 2017", "AUG 1, 2017", "AUG 14, 2017", "AUG 1, 2017", "JUL 27, 2017", "JUL 26, 2017", "JUL 21, 2017", "JUL 20, 2017", "JUL 17, 2017", "JUL 3, 2017", "AUG 1, 2017", "JUN 29, 2017", "JUN 28, 2017", "JUN 28, 2017", "JUN 28, 2017", "JUN 22, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 30, 2017", "MAY 6, 2017", "MAY 1, 2017", "APR 11, 2017", "APR 7, 2017", "MAR 31, 2017", "MAR 24, 2017", "MAR 21, 2017", "MAY 31, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 21, 2017", "MAR 2, 2017", "MAR 1, 2017", "FEB 24, 2017", "FEB 8, 2017", "FEB 3, 2017", "JAN 13, 2017", "DEC 16, 2016", "MAR 9, 2017", "SEP 20, 2016", "AUG 26, 2016", "JUL 13, 2016", "JUL 7, 2016", "JUN 29, 2016", "JUN 29, 2016", "NOV 1, 2016", "SEP 21, 2016", "SEP 20, 2016", "MAY 16, 2016", "MAR 15, 2016", "FEB 26, 2016", "JAN 20, 2016", "JAN 19, 2016", "JUN 29, 2016", "JUN 29, 2016", "JUN 20, 2016", "MAY 16, 2016", "NOV 4, 2015", "OCT 19, 2015", "OCT 12, 2015", "OCT 12, 2015", "JAN 14, 2016", "SEP 30, 2015", "SEP 30, 2015", "SEP 29, 2015", "SEP 29, 2015", "SEP 29, 2015", "SEP 29, 2015", "AUG 19, 2015", "SEP 30, 2015", "AUG 18, 2015", "AUG 17, 2015", "AUG 17, 2015", "AUG 17, 2015", "AUG 11, 2015", "AUG 10, 2015", "JUL 28, 2015", "AUG 19, 2015", "JUL 8, 2015", "JUL 7, 2015", "JUN 30, 2015", "JUN 25, 2015", "JUN 24, 2015", "JUN 18, 2015", "JUN 10, 2015", "JUL 9, 2015", "JUN 3, 2015", "APR 23, 2015", "APR 19, 2015", "APR 18, 2015", "APR 18, 2015", "APR 1, 2015", "MAR 30, 2015", "JUN 10, 2015", "MAR 26, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 22, 2015", "MAR 19, 2015", "MAR 19, 2015", "MAR 18, 2015", "MAR 28, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 5, 2015", "FEB 9, 2015", "FEB 4, 2015", "FEB 3, 2015", "JAN 5, 2015", "MAR 18, 2015", "NOV 18, 2014", "NOV 18, 2014", "OCT 13, 2014", "OCT 7, 2014", "OCT 6, 2014", "OCT 2, 2014", "OCT 2, 2014", "DEC 11, 2014", "SEP 25, 2014", "SEP 11, 2014", "JUL 14, 2014", "JUN 20, 2014", "MAR 10, 2014", "JUN 28, 2013", "JUN 26, 2013", "SEP 25, 2014", "MAY 14, 2013", "JUN 12, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oil-stocks-airlines-peloton-paypal-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-paypal-gm-lyft-airlines-2020-05-07", "https://www.nasdaq.com/articles/esperion-therapeutics-breaks-above-200-day-moving-average-bullish-for-espr-2020-05-07", "https://www.nasdaq.com/articles/esperion-therapeutics-inc-espr-q1-2020-earnings-call-transcript-2020-05-07", "https://www.nasdaq.com/articles/cycc-in-stopcovid-exel-hits-new-high-nvs-trialing-malaria-drug-for-covid-19-2020-04-21", "https://www.nasdaq.com/articles/should-you-buy-these-4-biotech-stocks-with-recent-drug-approvals-2020-04-15", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gilead-sciences-wayfair-immunomedics-akers-bioscience-2020-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-carnival-corp-capri-holdings-kohls-immunomedics-2020-04-06", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oil-stocks-airlines-peloton-paypal-2020-05-07", "https://www.nasdaq.com/articles/fda-approves-new-ldl-c-lowering-drug-nexletol-2020-02-22", "https://www.nasdaq.com/articles/fda-approves-esperion-therapeutics-new-cholesterol-drug-2020-02-21", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-espr-yumc-vsat-2020-02-07", "https://www.nasdaq.com/articles/4-dates-biotech-investors-should-circle-in-february-2020-02-06", "https://www.nasdaq.com/articles/european-advisory-group-backs-esperions-cholesterol-drugs-2020-01-31", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-february-2020-2020-01-28", "https://www.nasdaq.com/articles/biotechs-most-volatile-binary-events-for-q1-2020-01-03", "https://www.nasdaq.com/articles/esperion-therapeutics-breaks-below-200-day-moving-average-notable-for-espr-2020-03-09", "https://www.nasdaq.com/articles/4-healthcare-stocks-with-fda-approvals-on-the-horizon-2019-12-12", "https://www.nasdaq.com/articles/can-cannabis-2.0-kickstart-marijuana-stocks-2019-12-06", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-espr-dy-spot-2019-11-18", "https://www.nasdaq.com/articles/esperion-therapeutics-breaks-above-200-day-moving-average-bullish-for-espr-2019-11-18", "https://www.nasdaq.com/articles/analysts-forecast-10-gains-ahead-for-the-holdings-of-vb-2019-11-12", "https://www.nasdaq.com/articles/7-micro-cap-and-small-cap-stocks-that-insiders-are-buying-2019-09-09", "https://www.nasdaq.com/articles/monday-9-9-insider-buying-report%3A-achc-espr-2019-09-09", "https://www.nasdaq.com/articles/esperion-espr-almost-doubled-in-2019-what-awaits-the-stock-in-2020-2020-01-03", "https://www.nasdaq.com/articles/esperion-therapeutics-breaks-below-200-day-moving-average-notable-for-espr-2019-06-28", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-kem-espr-bac-2019-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-06-2019%3A-poddbhcbhc.toesprhmsy-2019-05-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-06-2019%3A-bhcesprhmsy-2019-05-06", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-shares-cross-above-200-dma-2019-05-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-06-2019%3A-espr-axsm-canf-jnj-pfe-abt-mrk-amgn-2019-05-06", "https://www.nasdaq.com/articles/commit-buy-esperion-therapeutics-25-earn-172-using-options-2019-04-24", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-itw-espr-team-2019-08-05", "https://www.nasdaq.com/articles/notable-monday-option-activity-hri-espr-clvs-2019-04-15-0", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-xop-2019-04-02", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-xop-2019-04-02-0", "https://www.nasdaq.com/articles/esperion-espr-reports-wider-than-expected-loss-in-q4-2019-03-01", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-espr-2019-02-06", "https://www.nasdaq.com/articles/esperion-therapeutics-2019-could-be-big-year-2019-01-11", "https://www.nasdaq.com/articles/health-care-sector-update-01042019-flks-nvax-espr-jnj-pfe-abt-mrk-amgn-2019-01-04", "https://www.nasdaq.com/articles/notable-monday-option-activity-hri-espr-clvs-2019-04-15", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-espr-ntnx-sldb-2019-01-04", "https://www.nasdaq.com/articles/notable-thursday-option-activity-espr-adbe-rgld-2018-12-20", "https://www.nasdaq.com/articles/look-under-hood-ftxh-has-35-upside-2018-12-17", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-esperion-espr-stock-we-dont-2018-11-14", "https://www.nasdaq.com/articles/whats-next-esperion-therapeutics-cholesterol-lowering-drug-2018-11-08", "https://www.nasdaq.com/articles/espr-makes-bullish-cross-above-critical-moving-average-2018-11-02", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-october-2018-10-20", "https://www.nasdaq.com/articles/why-arcus-biosciences-eldorado-gold-and-esperion-therapeutics-slumped-today-2019-01-04", "https://www.nasdaq.com/articles/notable-monday-option-activity-cmg-osis-espr-2018-10-08", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-xlnx-pdce-espr-2018-09-28", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-twtr-fslr-espr-2018-09-12", "https://www.nasdaq.com/articles/3-biotech-stocks-could-soar-september-2018-09-02", "https://www.nasdaq.com/articles/esperion-espr-combination-regimen-lowers-bad-cholesterol-2018-08-28", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-espr-bmy-watt-2018-08-27", "https://www.nasdaq.com/articles/commit-purchase-esperion-therapeutics-35-earn-345-annualized-using-options-2018-08-22", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-kre-2018-10-16", "https://www.nasdaq.com/articles/health-care-sector-update-08172018-esprvcelaray-2018-08-17", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-08-13", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-esperion-therapeutics-espr-stock-2018-07-10", "https://www.nasdaq.com/articles/oversold-conditions-esperion-therapeutics-espr-2018-05-24", "https://www.nasdaq.com/articles/esperion-therapeutics-inc-buy-dip-2018-05-08", "https://www.nasdaq.com/articles/heres-why-esperion-therapeutics-inc-stock-bouncing-back-today-2018-05-04", "https://www.nasdaq.com/articles/clinical-stage-biotechs-tackling-huge-health-issue-it-has-overcome-pessimistic-investors", "https://www.nasdaq.com/articles/health-care-sector-update-08172018-cgcarayesprvcel-2018-08-17", "https://www.nasdaq.com/articles/esperion-therapeutics-inc-shares-plunge-cholesterol-drug-safety-concerns-2018-05-02", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mixed-apple-earnings-top-expectations-2018-05-02", "https://www.nasdaq.com/articles/heres-why-esperion-therapeutics-dropped-much-369-today-2018-05-02", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-right-now-2018-05-01", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-esperion-espr-stock-2018-04-30", "https://www.nasdaq.com/articles/10-small-cap-growth-stocks-buy-now-2018-04-26", "https://www.nasdaq.com/articles/results-renew-optimism-esperion-therapeutics-2018-03-27", "https://www.nasdaq.com/articles/why-esperion-therapeutics-shares-are-crashing-again-today-2018-05-03", "https://www.nasdaq.com/articles/regeneron-takes-aim-amgen-and-esperion-therapeutics-2018-03-12", "https://www.nasdaq.com/articles/why-esperion-therapeutics-shares-fell-despite-its-good-news-2018-03-07", "https://www.nasdaq.com/articles/health-care-sector-update-03072018-espr-apto-flks-trvn-2018-03-07", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-esperion-espr-stock-2018-03-02", "https://www.nasdaq.com/articles/3-top-cholesterol-drug-stocks-consider-buying-now-2018-02-06", "https://www.nasdaq.com/articles/notable-friday-option-activity-blk-espr-czr-2018-01-12", "https://www.nasdaq.com/articles/why-esperion-therapeutics-shares-skyrocketed-4259-2017-2018-01-06", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-gpro-espr-intc-2018-03-27", "https://www.nasdaq.com/articles/beware-price-wars-big-pharma-biotech-companies-horizon-2017-12-15", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-dish-espr-goog-2017-12-06", "https://www.nasdaq.com/articles/3-stocks-quadrupled-2017-12-04", "https://www.nasdaq.com/articles/esperion-therapeutics-becomes-oversold-espr-2017-10-23", "https://www.nasdaq.com/articles/dows-merck-bails-cholesterol-drug-prodding-shares-down-2017-10-11", "https://www.nasdaq.com/articles/these-stocks-have-quadrupled-last-year-2017-08-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-mylan-perrigo-esperions-zynerba-and-valeant-2017-08-14", "https://www.nasdaq.com/articles/commit-purchase-esperion-therapeutics-28-earn-204-using-options-2017-12-21", "https://www.nasdaq.com/articles/pharma-stock-roundup-mylan-misses-perrigo-tops-q2-zynerba-plunges-study-failure-2017-08-11", "https://www.nasdaq.com/articles/heres-whats-pushing-esperion-therapeutics-inc-today-2017-08-08", "https://www.nasdaq.com/articles/health-care-sector-update-08082017-espr-2017-08-08", "https://www.nasdaq.com/articles/perrigo-company-prgo-q2-earnings%3A-whats-in-the-cards-2017-08-07", "https://www.nasdaq.com/articles/should-you-buy-esperion-therapeutics-espr-ahead-of-earnings-2017-08-07", "https://www.nasdaq.com/articles/whats-in-store-for-intrexon-xon-in-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-endo-endp-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/boxer-capital-llc-buys-macrogenics-inc-g1-therapeutics-inc-ipath-sp-500-vix-short-term", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-ionis-ions-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/juno-therapeutics-juno-q2-earnings%3A-surprise-in-store-2017-07-27", "https://www.nasdaq.com/articles/ceo-behind-lipitor-working-promising-new-cholesterol-drug-2017-07-26", "https://www.nasdaq.com/articles/3-been-there-done-biotech-ceos-who-are-doing-it-again-2017-07-21", "https://www.nasdaq.com/articles/thursdays-etf-movers-xbi-oih-2017-07-20", "https://www.nasdaq.com/articles/3-small-biotech-stocks-being-run-proven-winners-2017-07-17", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-merck-sanofi-roche-esperion-and-teva-2017-07-03", "https://www.nasdaq.com/articles/what-to-expect-from-epizyme-epzm-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-looks-good%3A-stock-gains-10.4-2017-06-29", "https://www.nasdaq.com/articles/esperions-combo-cholesterol-candidate-enters-phase-iii-2017-06-28", "https://www.nasdaq.com/articles/heres-why-shares-esperion-therapeutics-espr-popped-today-2017-06-28", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-espr-aapl-cmg-2017-06-28", "https://www.nasdaq.com/articles/if-esperion-wants-market-next-big-cholesterol-drug-it-will-take-strategy-2017-06-22", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-ibb-2017-06-21", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xbi-xop-2017-06-21", "https://www.nasdaq.com/articles/3-stocks-turned-7000-much-37000-so-far-2017-2017-06-30", "https://www.nasdaq.com/articles/why-esperion-therapeutics-shares-were-flat-april-2017-05-06", "https://www.nasdaq.com/articles/3-best-biotech-stocks-during-trumps-first-100-days-2017-05-01", "https://www.nasdaq.com/articles/3-clinical-stage-biotech-stocks-could-be-about-strike-it-rich-2017-04-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-esperion-therapeutics-vertex-pharmaceuticals-nektar", "https://www.nasdaq.com/articles/could-pfizer-buy-esperion-therapeutics-2017-03-31", "https://www.nasdaq.com/articles/3-hot-biotech-stocks-now-2017-03-24", "https://www.nasdaq.com/articles/company-news-for-march-21-2017-2017-03-21", "https://www.nasdaq.com/articles/commit-purchase-esperion-therapeutics-27-earn-212-annualized-using-options-2017-05-31", "https://www.nasdaq.com/articles/pre-market-most-active-mar-20-2017-lyg-arry-espr-gnmx-hmc-nktr-db-sny-syt-bac-arlz-asml", "https://www.nasdaq.com/articles/heres-what-pushed-esperion-therapeutics-inc-stock-higher-today-2017-03-20", "https://www.nasdaq.com/articles/close-update-wall-street-struggles-find-direction-fed-speakers-focus-2017-03-20", "https://www.nasdaq.com/articles/health-care-sector-update-03202017-ctmxbmyesprcerunvs-2017-03-20", "https://www.nasdaq.com/articles/health-care-sector-update-03202017-nktresprceru-2017-03-20", "https://www.nasdaq.com/articles/notable-friday-option-activity-hpt-espr-lmt-2017-03-17", "https://www.nasdaq.com/articles/heres-why-amgen-medicines-company-and-esperion-therapeutics-are-all-tanking-today-2017-03", "https://www.nasdaq.com/articles/pre-market-most-active-mar-21-2017-db-nok-auph-fcx-aapl-fcau-espr-qqq-bac-spil-fb-mt-2017", "https://www.nasdaq.com/articles/4-biotech-stocks-breaking-out-positive-drug-developments-2017-03-02", "https://www.nasdaq.com/articles/heres-why-esperion-therapeutics-inc-stock-popped-today-2017-03-01", "https://www.nasdaq.com/articles/3-biotech-long-shots-boom-or-bust-2017-02-24", "https://www.nasdaq.com/articles/4-stocks-watch-led-biotech-2017-02-08", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-soaring-today-2017-02-03", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-tsro-espr-lope-2017-01-13", "https://www.nasdaq.com/articles/notable-friday-option-activity-espr-smg-w-2016-12-16", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-jumps%3A-stock-moves-up-8.6-2017-03-09", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-espr-opht-fds-2016-09-20", "https://www.nasdaq.com/articles/is-esperion-therapeutics-espr-stock-a-solid-choice-right-now-2016-08-26", "https://www.nasdaq.com/articles/esperion-director-buys-4400-shares-2016-07-13", "https://www.nasdaq.com/articles/thursday-77-insider-buying-report-espr-xplr-2016-07-07", "https://www.nasdaq.com/articles/esperion-espr-offers-updates-on-ldl-lowering-candidate-2016-06-29", "https://www.nasdaq.com/articles/why-aerovironment-southwestern-energy-and-esperion-therapeutics-slumped-today-2016-06-29", "https://www.nasdaq.com/articles/pfizers-surprising-news-upends-market-next-gen-cholesterol-busters-2016-11-01", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-in-focus%3A-stock-jumps-18.1-2016-09-21", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-espr-opht-fds-2016-09-20", "https://www.nasdaq.com/articles/component-price-targets-imply-17-gains-ahead-russell-2000-2016-05-16", "https://www.nasdaq.com/articles/tuesdays-etf-movers-gdx-xbi-2016-03-15", "https://www.nasdaq.com/articles/health-care-sector-update-02262016-espr-kerx-2016-02-26", "https://www.nasdaq.com/articles/wednesday-120-insider-buying-report-fmo-espr-2016-01-20", "https://www.nasdaq.com/articles/why-chimerix-inc-big-today-2016-01-19", "https://www.nasdaq.com/articles/why-alcoa-inc-aa-esperion-therapeutics-inc-espr-and-southwestern-energy-company-swn-are-3", "https://www.nasdaq.com/articles/esperion-therapeutics-inc-sinks-after-fda-says-ask-us-2019-2016-06-29", "https://www.nasdaq.com/articles/russell-2000-headed-14-higher-if-analysts-got-components-right-2016-06-20", "https://www.nasdaq.com/articles/sucampo-scmp-misses-on-q3-earnings-focus-on-amitiza-2015-11-05", "https://www.nasdaq.com/articles/endocyte-ecyt-posts-narrower-than-expected-loss-in-q3-2015-11-04", "https://www.nasdaq.com/articles/eli-lillys-failure-success-these-companies-2015-10-19", "https://www.nasdaq.com/articles/pre-market-most-active-oct-12-2015-emc-lly-pstg-aapl-sny-alu-abx-espr-tvix-xiv-mu-nflx", "https://www.nasdaq.com/articles/winners-and-losers-eli-lillys-cetp-drug-failure-2015-10-12", "https://www.nasdaq.com/articles/esperion-espr-initiates-phase-iii-study-for-hyperlipidemia-2016-01-14", "https://www.nasdaq.com/articles/esperion-plunges-on-fda-advice-for-cardiovascular-study-2015-09-30", "https://www.nasdaq.com/articles/health-care-sector-update-09302015-esprmdwdhae-2015-09-30", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-stock-cratered-today-2015-09-29", "https://www.nasdaq.com/articles/health-care-sector-update-09292015-egrx-espr-gtxi-2015-09-29", "https://www.nasdaq.com/articles/tuesdays-etf-movers-gdx-xbi-2015-09-29", "https://www.nasdaq.com/articles/tuesday-sector-laggards-waste-management-drugs-2015-09-29", "https://www.nasdaq.com/articles/esperion-updates-on-its-cholesterol-management-candidate-2015-08-19", "https://www.nasdaq.com/articles/health-care-sector-update-09302015-espr-blph-ogxi-2015-09-30", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-catches-eye%3A-stock-up-14.1-2015-08-18", "https://www.nasdaq.com/articles/esperion-espr-sees-hammer-chart-pattern%3A-time-to-buy-2015-08-17", "https://www.nasdaq.com/articles/after-hours-most-active-aug-17-2015-abbv-abev-sune-ccp-tsm-hst-urbn-espr-cenx-qqq-car-msft", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-pin-2015-08-17", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-looks-good%3A-stock-up-16.3-tale-of-the-tape-2015-08-11", "https://www.nasdaq.com/articles/health-care-sector-update-08102015-pmc-myl-espr-2015-08-10", "https://www.nasdaq.com/articles/esperion-therapeutics-becomes-oversold-espr-2015-07-28", "https://www.nasdaq.com/articles/esperions-good-news-actually-bad-2015-08-19", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-jumps%3A-stock-rises-7.1-tale-of-the-tape-2015-07-08", "https://www.nasdaq.com/articles/health-care-sector-update-07072015-esprdepohznpetrm-2015-07-07", "https://www.nasdaq.com/articles/pabrai-funds-2014-investor-meeting-notes-2015-06-30", "https://www.nasdaq.com/articles/health-care-sector-update-06252015-oprn-espr-mack-2015-06-25", "https://www.nasdaq.com/articles/health-care-sector-update-06242015-aldr-ptla-espr-2015-06-24", "https://www.nasdaq.com/articles/calls-target-esperion-therapeutics-2015-06-18", "https://www.nasdaq.com/articles/cholesterol-drug-blues-why-esperion-therapeutics-stock-getting-crushed-today-2015-06-10", "https://www.nasdaq.com/articles/fda-breathes-new-life-esperions-etc-1002-2015-07-09", "https://www.nasdaq.com/articles/3-biotech-stocks-you-might-not-know-about-ought-consider-buying-2015-06-03", "https://www.nasdaq.com/articles/health-care-sector-update-04232015-stj-espr-adpt-2015-04-23", "https://www.nasdaq.com/articles/3-biotech-stocks-could-be-developing-billion-dollar-drugs-2015-04-19", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-surging-higher-year-2015-04-18", "https://www.nasdaq.com/articles/3-best-stocks-investing-cholesterol-drugs-2015-04-18", "https://www.nasdaq.com/articles/heres-how-esperion-therapeutics-inc-could-get-140-2015-04-01", "https://www.nasdaq.com/articles/healthcare-merger-monday-these-3-stocks-could-be-healthcares-next-buyout-targets-2015-03", "https://www.nasdaq.com/articles/pre-market-most-active-jun-10-2015-nem-gsk-asx-nok-hcc-caj-issi-gpro-aapl-espr-xiv-qqq", "https://www.nasdaq.com/articles/3-biotech-stocks-dropped-yesterday-1-buy-2015-03-26", "https://www.nasdaq.com/articles/weakness-seen-in-esperion-therapeutics-espr%3A-stock-tumbles-8.8-tale-of-the-tape-2015-03-25", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-shares-burst-today-2015-03-25", "https://www.nasdaq.com/articles/1-tiny-biotechs-blockbuster-opportunity-heart-disease-2015-03-22", "https://www.nasdaq.com/articles/health-care-sector-update-03192015-flml-nbix-espr-capr-2015-03-19", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-sky-rocketing-higher-2015-03-19", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-jumps%3A-stock-rises-29.2-tale-of-the-tape-2015-03-18", "https://www.nasdaq.com/articles/3-little-known-biotechs-working-potential-blockbusters-2015-03-28", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-stock-bolted-higher-today-2015-03-17", "https://www.nasdaq.com/articles/health-care-sector-update-03172015-esprcnat-2015-03-17", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-5-2015-coo-esl-wx-fnsr-tfm-yy-mmi-espr-ttph-ebs-jobs-ent", "https://www.nasdaq.com/articles/3-all-or-nothing-biotech-stocks-were-closely-watching-2015-02-09", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-jumps%3A-stock-rises-15.6-tale-of-the-tape-2015-02-04", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-shares-skyrocketed-today-2015-02-03", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-shares-march-higher-can-it-continue-tale-of-the-tape-2015-01-05", "https://www.nasdaq.com/articles/esperion-soars-on-positive-phase-iib-data-on-etc-1002-analyst-blog-2015-03-18", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-esperion-espr-tale-of-the-tape-2014-11-18", "https://www.nasdaq.com/articles/merck-improves-it-causing-these-biotechs-stock-prices-improve-too-2014-11-18", "https://www.nasdaq.com/articles/esperion-therapeutics-slumps%3A-espr-falls-6.3-in-session-tale-of-the-tape-2014-10-13", "https://www.nasdaq.com/articles/should-pfizer-inc-buy-surprisingly-competitive-biotech-stock-2014-10-07", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-in-focus%3A-stock-jumps-5.1-tale-of-the-tape-2014-10-06", "https://www.nasdaq.com/articles/sector-update-health-care-stocks-again-springing-leaks-esperion-therapeutics-climbs-record", "https://www.nasdaq.com/articles/sector-update-health-care-2014-10-02-1", "https://www.nasdaq.com/articles/can-the-rally-in-esperion-therapeutics-espr-shares-continue-tale-of-the-tape-2014-12-11", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-in-focus%3A-stock-up-13.4-tale-of-the-tape-2014-09-25", "https://www.nasdaq.com/articles/nasdaq-biotechnology-top-performers-market-open-september-11-2014-09-11", "https://www.nasdaq.com/articles/mediwound-mdwd-falls%3A-stock-goes-down-6.1-tale-of-the-tape-2014-07-14", "https://www.nasdaq.com/articles/aerie-pharmaceuticals-aeri-in-focus%3A-stock-moves-6.8-higher-tale-of-the-tape-2014-06-20", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-in-focus%3A-stock-moves-5.6-higher-tale-of-the-tape-2014-03-10", "https://www.nasdaq.com/articles/us-ipo-recap-market-picks-pace-ten-ipos-six-price-below-range-2013-06-28", "https://www.nasdaq.com/articles/esperion-therapeutics-prices-upsized-ipo-14-midpoint-range-2013-06-26", "https://www.nasdaq.com/articles/esperion-espr-is-in-overbought-territory%3A-whats-next-tale-of-the-tape-2014-09-25", "https://www.nasdaq.com/articles/esperion-therapeutics-files-70-million-ipo-2013-05-14", "https://www.nasdaq.com/articles/biotech-esperion-therapeutics-sets-terms-63-million-ipo-2013-06-12"], "Content": []}